Anxo Pharmaceutical Co Ltd
TPEX:6677
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
A
|
Anxo Pharmaceutical Co Ltd
TPEX:6677
|
TW |
|
T
|
Turbon AG
F:TUR
|
DE |
|
Vyborgskiy Sudostroitel'nyi Zavod PAO
MOEX:VSYDP
|
RU |
|
MPR Australia Ltd
ASX:MPR
|
AU |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de Anxo Pharmaceutical Co Ltd.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace Anxo Pharmaceutical
Anxo Pharmaceutical Co., Ltd. provides service for industry in developing analytical methodology, validation and various pharmaceutical dosage forms. The company is headquartered in Taipei City, Taipei. The company went IPO on 2018-06-27. The firm's main products include oral preparations (tablets, capsules, liquids, inhalation preparations), injections and topical preparations for the treatment of cardiovascular, central nervous system, endocrine, antimicrobial, urinary tract and blood and kidney diseases. The firm mainly operates in the Taiwan market as well as overseas markets.
- Sede central
- Taiwán TW
- Fecha de salida a bolsa
- 27 jun., 2018